60 DEGREES PHARMACEUTICALS, INC.
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
SXTP | NDAQ
Overview
Corporate Details
- ISIN(s):
- US83006G1040
- LEI:
- Country:
- United States of America
- Address:
- 1025 CONNECTICUT AVENUE NW, 20036 WASHINGTON
- Website:
- https://60degreespharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
60 Degrees Pharmaceuticals, Inc., established in 2010, is a specialty pharmaceutical company focused on the development and commercialization of medicines to treat and prevent infectious diseases. The company primarily targets tropical diseases with significant unmet medical needs, such as malaria and dengue fever. Its key commercial product is ARAKODA® (tafenoquine), a therapy for malaria prevention. The company's mission is to develop innovative therapeutic solutions to improve the quality of life for affected populations worldwide, including travelers to endemic regions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all 60 DEGREES PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 60 DEGREES PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 60 DEGREES PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
